NotiSphere was selected to Galen Growth's HealthTech 250; The HealthTech 250 is Galen Growth’s selection of the 250 most promising early-stage Digital Health ventures across the globe in 2022.
Since 2017, Galen Growth has tracked and reported on the Digital Health innovation across the globe. Galen Growth's data, intel and insights allows to uniquely assess, identify and showcase the most promising early stage Digital Health ventures in the world.
The ventures are located across the 5 largest regions for Digital Health – North and South America, Asia Pacific, Europe and the Middle East. All ventures provide solutions across the entire patient journey from prevention to reimbursement, including wellness solutions, digital therapeutics, research, and clinical trial support.
A selection algorithm that ranked the ventures based on indices, including a proprietary Alpha Score, recent partnerships, news sentiment, clinical strength, key team members, regulatory approvals and clinical strength was used to select the most promising early-stage Digital Health ventures. The market maturity and total volume of ventures within the key geographies were taken into account to generate a weighted distribution of ventures.